 |
|
Cinnamic acid derivatives as potential matrix metalloproteinase-9 inhibitors: molecular docking and dynamics simulations
Mohammad Hossein Malekipour, Farzaneh Shirani, Shadi Moradi, Amir Taherkhani
Genomics Inform. 2023;21(1):e9 Published online 2023 Mar 31 DOI: https://doi.org/10.5808/gi.22077
|
|
Citations to this article as recorded by
 Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel
Delivery Systems of Chlorogenic Acid for the Management of Diseases with a
Special Emphasis on Ulcerative Colitis
Ranjit K. Harwansh, Hemant Bhati, Rohitas Deshmukh
Current Pharmaceutical Design.2024; 30(6): 420. CrossRef Exploring Cinnamic Acids as Potent Antimetastatic Agents for Cancer Therapy: Molecular Docking and Dynamic Simulation against MMP2
Setareh Shojaei, Mohammad-Reza Zandieh, Shokoofeh Jamshidi, Amir Taherkhani, Zahra Azadian, Faisal Raza
European Journal of Cancer Care.2024; 2024: 1. CrossRef Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment
Zainab Ahmed Rashid, Sanaa K. Bardaweel
International Journal of Molecular Sciences.2023; 24(15): 12133. CrossRef Caffeic Acid in Spent Coffee Grounds as a Dual Inhibitor for MMP-9 and DPP-4 Enzymes
Enade P. Istyastono, Nunung Yuniarti, Vivitri D. Prasasty, Sudi Mungkasi, Stephanus S. W. Waskitha, Michael R. S. Yanuar, Florentinus D. O. Riswanto
Molecules.2023; 28(20): 7182. CrossRef
|